跳转至内容
Merck
CN
  • Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.

Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.

Scientific reports (2016-02-26)
Ryoichi Shima, Tian Cheng Li, Yutaka Sendai, Chikako Kataoka, Yoshio Mori, Takayuki Abe, Naokazu Takeda, Toru Okamoto, Yoshiharu Matsuura
摘要

Hepatitis E virus (HEV) causes not only endemics via a fecal-oral route but also sporadic cases via zoonotic transmission or blood transfusion. HEV-like particles (HEV-LP) produced by using a baculovirus expression system are considered a candidate for mucosal vaccines for HEV infection. In this study, we attempted to produce a chimeric HEV-LP presenting various foreign epitopes on its surface. Expression of the recombinant capsid proteins carrying a myc- or FLAG-tag inserted between amino acid residues 488 and 489, which are located in the exterior loop on the protruding domain of the HEV capsid, resulted in the production of recombinant HEV-LP. Although expression of the recombinant capsid protein carrying the HA-tag inserted at the same site failed to produce any particles, co-expression with the myc-tagged capsid protein successfully yielded a chimeric HEV-LP consisting of both recombinant capsid proteins. Immunoprecipitation analyses confirmed that the chimeric particles present these foreign epitopes on the surface. Similar results were obtained for the expression of the recombinant capsid proteins carrying neutralizing epitopes of Japanese encephalitis virus. These results suggest the chimeric HEV-LP system provides a novel vaccine carrier that can accommodate multiple neutralizing epitopes on its surface.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Anti-c-Myc抗体,小鼠单克隆 小鼠抗, clone 9E10, purified from hybridoma cell culture
Sigma-Aldrich
单克隆抗 FLAG ® M5 小鼠抗, clone M5, purified immunoglobulin, buffered aqueous solution